PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
PD1 Combined With Chemotherapy for Adjuvant Treatment of Gastric Cancer	Gastric or Esophagogastric Junction Adenocarcinoma	Active, not recruiting	Phase 3	2026-07-07		NCT05180734

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanghai Junshi Bioscience Co., Ltd.	42

71 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Affiliated Cancer Hospital and Institute of Ghuangzhou Medical University	Guangzhou	China	1
Affiliated Hospital of Jining Medical University	Jining	China	1
Affiliated Hospital of Zunyi Medical University	Zunyi	China	3
Beijing Cancer hospital	Beijing	China	1
Beijing Friendship Hospital, Capital Medical University	Beijing	China	64
Beijing Hospital	Beijing	China	6
Cancer Hospital affiliated to Xinjiang Medical University	Ürümqi	China	1
China-Japan Union Hospital of Jilin University	Changchun	China	17
Chinese PLA General Hospital	Beijing	China	5
Fujian Provincial Cancer Hospital	Fuzhou	China	1
Gansu Provincial Cancer Hospital	Lanzhou	China	16
Gansu Provincial People's Hospital	Lanzhou	China	7
General Hospital of Ningxia Medical University	Yinchuan	China	5
Guandong General Hospital	Guangzhou	China	1
Guangxi Medical University Affiliated Tumor Hospital	Nanning	China	13
Harbin Medical University Cancer Hospital	Harbin	China	102
Henan Cancer Hospital	Zhengzhou	China	57
Hubei Cancer Hospital	Wuhan	China	95
Hunan Cancer Hopital	Changsha	China	1
Jiangmen Central Hospital	Nanchang	China	1
Jiangsu Cancer Hospital	Nanjing	China	12
Jiangsu Province Hospital	Nanjing	China	89
Jinan Central Hospital	Jinan	China	1
Lanzhou University Second Hospital	Lanzhou	China	7
Liaoning Cancer Hospital & Institute	Shenyang	China	4

Clinical trials